Ursodeoxycholic Acid capsule

Ursodeoxycholic Acid capsule

Form: Capsules

Strength: 150 mg, 300 mg

Reference Brands: Actigall(US), rsofalk, Ursocaps, Ursode(EU)

Category: Gastrointestinal Drugs

Ursodeoxycholic acid capsules, marketed as Actigall and Ursocaps, are approved in the US by the FDA and in the EU via EMA for gallstone dissolution and liver disease. Approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe use, and global availability, promoting gallstone management and liver health worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Sucralfate tablet

Strength: 1 g

Form: Tablets

Reference Brands: Carafate(US)

View Details Get Enquiry
Simethicone tablet

Strength: 40 mg

Form: Tablets

Reference Brands: Mylicon(US)

View Details Get Enquiry
Pancreatin Tablets

Strength: 10,000, 25,000, 40,000, 50,000, 80,000 USP units.

Form: Tablets

Reference Brands: Creon(US)

View Details Get Enquiry
L-Ornithine L-Aspartate powder

Strength: 5 g, 10 g, or 15 g

Form: Powder for Reconstitution for oral use

Reference Brands: Liv.52, HepaMerz(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.